Rock Springs Capital Management LP Fate Therapeutics Inc Transaction History

Rock Springs Capital Management LP

  • $2.94 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$4.24 - $11.12 $2.13 Million - $5.58 Million
502,215 Added 456.56%
612,215 $3.49 Million
Q3 2021

Nov 15, 2021
BUY
$59.27 - $95.73 $2.37 Million - $3.83 Million
40,000 Added 57.14%
110,000 $6.52 Million
Q1 2021

May 17, 2021
BUY
$72.16 - $117.4 $5.05 Million - $8.22 Million
70,000 New
70,000 $5.77 Million

Others Institutions Holding FATE

# of Institutions
177
Shares Held
113M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $133M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email